IL-4 plays a critical role in the differentiation of TCR-stimulated naive C
D4 T cells to the Th2 phenotype. In response to IL-4, the IL-4R activates a
set of phosphotyrosine binding domain-containing proteins, including insul
in receptor substrate 1/2, Shc, and IL-4R interacting protein, as well as S
tat6. Stat6 has been shown to be required for Th2 differentiation. To deter
mine the roles of the phosphotyrosine binding adaptors in Th2 differentiati
on, we prepared a retrovirus containing a mutant of the human (h)IL-4R alph
a -chain, Y497F, which is unable to recruit these adaptors. The mutant hIL-
4R alpha, as well as the wild-type (WT) hIL-4R alpha, was introduced into n
aive CD4 T cells. Upon hIL-4 stimulation, Y497F worked as well as the WT hI
L-4R alpha in driving Th2 differentiation, as measured by Gata3 up-regulati
on and IL-4 production. Furthermore, IL-4-driven cell expansion was also no
rmal in the cells infected with Y497F, although cells infected with Y497F w
ere not capable of phosphorylating insulin receptor substrate 2. These resu
lts suggest that the signal pathway mediated by Y497 is dispensable for bot
h IL-4-driven Th2 differentiation and cell expansion. Both WT and Y497F hIL
-4R alpha lose the ability to drive Th2 differentiation and cell expansion
in Stat6-knockout CD4 T cells. A constitutively activated form of Stat6 int
roduced into CD4 T cells resulted in both Th2 differentiation and enhanced
cell expansion. Thus, activated Stat6 is necessary and sufficient to mediat
e both IL-4-driven Th2 differentiation and cell expansion in CD4 T cells.